Laboratory testing for suspected COVID‐19 vaccine–induced (immune) thrombotic thrombocytopenia

COVID‐19 (coronavirus disease 2019) represents a pandemic, and several vaccines have been produced to prevent infection and/or severe sequelae associated with SARS‐CoV‐2 (severe acute respiratory syndrome coronavirus 2) infection. There have been several reports of infrequent post vaccine associated...

Full description

Saved in:

Bibliographic Details
Published in:	International journal of laboratory hematology Vol. 43; no. 4; pp. 559 - 570
Main Author:	Favaloro, Emmanuel J.
Format:	Journal Article
Language:	English
Published:	Chichester Wiley Subscription Services, Inc 01.08.2021 John Wiley and Sons Inc
Subjects:	Antibodies Complications Coronaviruses COVID-19 COVID-19 vaccines Enzyme-linked immunosorbent assay Fibrinogen Heparin Idiopathic thrombocytopenic purpura Immunology Laboratories laboratory testing Pandemics Platelet factor 4 platelet factor 4 antibodies Platelets Review Reviews Severe acute respiratory syndrome coronavirus 2 Thrombocytopenia Thrombosis thrombosis with thrombocytopenia syndrome Vaccines vaccine‐associated thrombotic thrombocytopenia vaccine‐induced (immune) thrombotic thrombocytopenia
ISSN:	1751-5521, 1751-553X, 1751-553X
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!